BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 27818386)

  • 1. Pediatric necrotizing myopathy associated with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies.
    Liang WC; Uruha A; Suzuki S; Murakami N; Takeshita E; Chen WZ; Jong YJ; Endo Y; Komaki H; Fujii T; Kawano Y; Mori-Yoshimura M; Oya Y; Xi J; Zhu W; Zhao C; Watanabe Y; Ikemoto K; Nishikawa A; Hamanaka K; Mitsuhashi S; Suzuki N; Nishino I
    Rheumatology (Oxford); 2017 Feb; 56(2):287-293. PubMed ID: 27818386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statin-naïve anti-HMGCR antibody-mediated necrotizing myopathy in China.
    Jiao Y; Cai S; Lin J; Zhu W; Xi J; Li J; Yue D; Zhang T; Qiao K; Wang Y; Zhao C; Lu J
    J Clin Neurosci; 2018 Nov; 57():13-19. PubMed ID: 30205933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy.
    Watanabe Y; Uruha A; Suzuki S; Nakahara J; Hamanaka K; Takayama K; Suzuki N; Nishino I
    J Neurol Neurosurg Psychiatry; 2016 Oct; 87(10):1038-44. PubMed ID: 27147697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statins and myotoxic effects associated with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase autoantibodies: an observational study in Japan.
    Watanabe Y; Suzuki S; Nishimura H; Murata KY; Kurashige T; Ikawa M; Asahi M; Konishi H; Mitsuma S; Kawabata S; Suzuki N; Nishino I
    Medicine (Baltimore); 2015 Jan; 94(4):e416. PubMed ID: 25634171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy.
    Mammen AL; Chung T; Christopher-Stine L; Rosen P; Rosen A; Doering KR; Casciola-Rosen LA
    Arthritis Rheum; 2011 Mar; 63(3):713-21. PubMed ID: 21360500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statins and myositis: the role of anti-HMGCR antibodies.
    Selva-O'Callaghan A; Alvarado-Cardenas M; Marin A; Pinal-Fernandez I
    Expert Rev Clin Immunol; 2015; 11(12):1277-9. PubMed ID: 26492593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spontaneous symptomatic improvement in a pediatric patient with anti-3-hydroxy-3-methylglutraryl-coenzyme A reductase myopathy.
    Suárez B; Jofré J; Lozano-Arango A; Ortega X; Diaz J; Calcagno G; Bevilacqua JA; Castiglioni C
    Neuromuscul Disord; 2020 Jun; 30(6):503-509. PubMed ID: 32518057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concurrent positive anti-3-hydroxy-3-methylglutaryl-coenzyme a reductase antibody with reducing body myopathy: Possible double trouble.
    Tanboon J; Sanmaneechai O; Charuvanij S; Sangruchi T; Galindo-Feria AS; Lundberg IE; Ohnuki Y; Shiina T; Suzuki S; Nishino I
    Neuromuscul Disord; 2019 Jul; 29(7):543-548. PubMed ID: 31204143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-hydroxy-3-methylglutaryl-coenzyme A reductase (anti-HMGCR) antibody in necrotizing myopathy: treatment outcomes, cancer risk, and role of autoantibody level.
    Aggarwal R; Moghadam-Kia S; Lacomis D; Malik A; Qi Z; Koontz D; Burlingame RW; Oddis CV
    Scand J Rheumatol; 2020 Sep; 49(5):405-411. PubMed ID: 31801390
    [No Abstract]   [Full Text] [Related]  

  • 10. Anti-HMGCR Antibody-Positive Myopathy Shows Bcl-2-Positive Inflammation and Lymphocytic Accumulations.
    Kurashige T; Murao T; Mine N; Sugiura T; Inazuka Y; Kuraoka K; Takahashi T; Maruyama H; Torii T
    J Neuropathol Exp Neurol; 2020 Apr; 79(4):448-457. PubMed ID: 32100014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proposed cut-off for reactivity of anti-HMGCR and anti-SRP antibodies in patients statin-exposed and statin-unexposed.
    Carvalho AAS; Silva VGD; Vieira TF; Delgado PO; Corazini R; Feder D; Fonseca FLA
    Medicine (Baltimore); 2018 Aug; 97(35):e11858. PubMed ID: 30170376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmune necrotising myopathy and HMGCR antibodies.
    Karunaratne K; Amiras D; Pickering MC; Hofer M; Viegas S
    Pract Neurol; 2018 Apr; 18(2):151-155. PubMed ID: 29439058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Characteristics of Anti-3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Antibodies in Chinese Patients with Idiopathic Inflammatory Myopathies.
    Ge Y; Lu X; Peng Q; Shu X; Wang G
    PLoS One; 2015; 10(10):e0141616. PubMed ID: 26509687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-3-hydroxy-3-methylglutaryl-coenzyme a reductase necrotizing myopathy masquerading as a muscular dystrophy in a child.
    Mohassel P; Foley AR; Donkervoort S; Fequiere PR; Pak K; Bönnemann CG; Mammen AL
    Muscle Nerve; 2017 Dec; 56(6):1177-1181. PubMed ID: 28066895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Childhood-onset anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase (anti-HMGCR) necrotizing myopathy needs to be distinguished from muscular dystrophy: A case study].
    Hama Y; Mori-Yoshimura M; Komaki H; Suzuki S; Kohsaka H; Nishino I; Takahashi Y
    Rinsho Shinkeigaku; 2017 Oct; 57(10):567-572. PubMed ID: 28966227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitophagy in three cases of immune-mediated necrotizing myopathy associated with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase autoantibodies: ultrastructural and immunohistochemical studies.
    Matsubara S; Bokuda K; Asano Y; Morishima R; Sugaya K; Miyamoto K; Koide R; Komori T; Suzuki S; Nishino I
    Neuromuscul Disord; 2018 Mar; 28(3):283-288. PubMed ID: 29402601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Screening of autoantibodies associated with necrotizing myopathy among undiagnosed chronic myopathy].
    Kuru S; Suzuki S; Ogata K; Kobayashi M; Ishida C; Watanabe C; Matsumura T
    Rinsho Shinkeigaku; 2017 Oct; 57(10):562-566. PubMed ID: 28954975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune-Mediated Necrotizing Myopathy.
    Pinal-Fernandez I; Casal-Dominguez M; Mammen AL
    Curr Rheumatol Rep; 2018 Mar; 20(4):21. PubMed ID: 29582188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibody-positive paraneoplastic necrotizing myopathy associated with advanced gastric cancer that responded to intravenous immunoglobulin therapy].
    Yamaguchi T; Matsunaga A; Ikawa M; Shirafuji N; Nishino I; Hamano T
    Rinsho Shinkeigaku; 2017 Mar; 57(3):118-123. PubMed ID: 28228619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: A history of statins and experience from a large international multi-center study.
    Musset L; Allenbach Y; Benveniste O; Boyer O; Bossuyt X; Bentow C; Phillips J; Mammen A; Van Damme P; Westhovens R; Ghirardello A; Doria A; Choi MY; Fritzler MJ; Schmeling H; Muro Y; García-De La Torre I; Ortiz-Villalvazo MA; Bizzaro N; Infantino M; Imbastaro T; Peng Q; Wang G; Vencovský J; Klein M; Krystufkova O; Franceschini F; Fredi M; Hue S; Belmondo T; Danko K; Mahler M
    Autoimmun Rev; 2016 Oct; 15(10):983-93. PubMed ID: 27491568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.